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Abstract
Objective: To determine the better cost-effective treatment strategy for ureteral stones in a health district of Eastern 
Spain. 
Methods: A total of 180 patients were treated between June 2012 and December 2013 for ureteral stones using 
two different strategies (SWL as initial treatment and URS as rescue technique vs URS and laser lithotripsy (up to 
2 procedures). We performed an economic evaluation through a cost effectiveness analysis comparing costs and 
outcome. We performed a differentiating model in patients with lithiasis less than 1 cm or equal to or larger than 1 
cm. The effectiveness parameter was the stone free rate (SFR), defined as the absence of lithiasis fragments or the 
presence of clinically insignificant residual fragments (CIRFs) - less than 3 mm at the 3 month follow up. A decision tree 
was developed and a Monte Carlo simulation was performed to establish uncertainty.
Results: The SWL as first line was equally or more effective and cheaper than URS as first line of treatment for 
ureteral stones regardless of location or size. The overall cost for SWL (plus URS as second line) was 1,445,86 € and its 
SFR was 99.7%, and 2,369,21 and 97.62% for URS group. After the Montecarlo sensitivity analysis, the SWL showed 
dominance or cost-effectiveness in the vast majority of times, for each position and size. 
Conclusions: SWL as first line of treatment was more efficient in terms of cost effectiveness than first line URS 
with Ho: YAG laser lithotripsy for ureteral stones. Given its level of stone clearance, a non-invasive, outpatient based 
treatment like lithotripsy should remain the first-line treatment option for ureteral stones.
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Introduction
The optimal treatments of ureteral stones are yet controversial. 
Although ureteral stones are known to fragment less effectively than 
renal stones, shockwave lithotripsy (ESWL) has remained the preferred 
treatment method because of its minimally invasive nature. However 
the advances in the design of the ureteroscopes have greatly impacted 
the management of ureteric stones. The introduction of small-caliber 
semirigid and flexible ureteroscopes, as well as reliable laser technology 
and the production of more robust flexible instruments have further 
expanded the indications for endoscopic intervention. These advances 
have improved the ureteroscopy stone-free rate and decreased the risk 
of complications. However, the magnitude and rate of introduction 
and the acceptance of new technology are major determinants of total 
healthcare costs [1,2]. In the context of limited expenditure on public 
health and overloaded national medical insurance, the urologist should 
find out the most cost-effective option to offer the patients best clinical 
outcome. There is an important gap in knowledge of this aspect in 
clinical practice. 
The purpose of this study was determining the better cost-effective 
treatment strategy for ureteral stones in Spanish medical setting. 
Material and Methods
From June 2012 and December 2013, 201 a prospective non-
randomized study was carry on. A total of 201 consecutive patients (180 
valid) with ureteral radiopaque calculi were treated with two different 
treatment strategies in a University hospital by two experienced 
urologist at our institution. A total of 21 patients were excluded for loss 
to follow up or non-completion of protocol designed:
ESWL Group (95 patients): ESWL as initial technique and URSL in 
case of unsuccessful treatment.
URSL Group (85 patients): Holmium Laser URSL as initial 
technique and a rescue URSL in case of unsuccessful treatment. 
Patients with the following conditions were excluded: Patients 
younger than 14 years, ureteral size stone higher than 2 cm, more 
than one stone, pregnancy, uncontrolled urinary tract infection, 
pyonephrosis, sepsis, renal insufficiency with serum creatinine greater 
than 3.0 mg/dL, hemorrhagic diathesis, important skeletal deformities, 
history of pelvic surgery or irradiation or open ureterolithotomy for 
treatment of the same side ureteral stones. 
An intravenous urography or enhanced or non enhanced CT scan 
was performed for all cases before treatment. Antibiotics treated urinary 
infections preoperatively. A sterile urine culture was obtained in all 
the cases before the surgery. Patients´ demographic parameters, stone 
feature, hospital stay, treatment outcome, per-operative complications 
and medical costs were addressed and compared between the two 
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groups. Before surgery all patients signed an informed consent form 
and the approval of the hospital ethical committee was obtained.
The assignment to treatment arm was performed according to the 
patient´s decision, after being adequately informed of the two initial 
treatment options and current recommendations in clinical guidelines. 
Each group was categorized according to the size of the stone treated 
(more or less than 1 cm). 
ESWL technique
The ESWL treatment was performed under analgesia with 
meperidine using a third generation electromagnetic lithotripter 
(Siemens Lithoskop, shockwave system Pulso, Erlangen, Germany). 
The treatment was performed on an outpatient basis. The shockwave 
system had an adjustable energy level (in 38 steps from 0.1 to 8) with 
a focal pressure (P+) from 8.9 MPa to 75.3 MPa. The shockwave 
energy at 12 mm ranged from 8 mJ to 117 mJ. The maximum focal 
width was 12 mm and the maximum penetration depth was 16 cm. 
Treatment was performed with the patient supine and the shockwave 
head in under table position. In all patients, X-ray was used for stone 
localization during ESWL treatment. The shock frequency was 120 
min. During one treatment session a median of 5.473 (DE 1.735.75) 
shockwaves were administered unless the stone was defragmented 
before. Treatment variables (administered number of shockwave, total 
applied energy) were recorded for each treatment. To assess therapy 
outcome, X-ray and US examination was usually performed 7 days 
after ESWL. The therapy was regarded as successful and the patients 
as stone free, when no more treatable stones were seen (no stone or 
stone<3 mm). Re-treatment was performed in cases of residual stones 
of >3 mm until a maximum of four sessions. If residual stones persisted 
after four sessions, an ureteroscopy was performed. If the problem was 
not resolved with the first intervention, the patient will undergo to a 
second ureteroscopy. Complete stone clearance was assessed at three 
months follow up. 
URSL technique
In all procedures a 0.035-inch guide-wire was coiled at the renal 
pelvis, followed by 6.5 Fr semirigid ureteroscopy (Karl Storz GmbH, 
Tuttlingen, Germany). Laser Lithotripsy unit (Stonelight® Holmium 
Laser System, AMS Inc, Minnetonka, MN, USA) was set at 0.7-1 
J energy pulses and 8 to 10 Hz frequency over a 550 μm laser fiber. 
If the ureteral access was not possible with a semirigid device, a 
flexible ureteroscope was used (Flex-XTM flexible ureteroscope, 7.5 
Fr × 6000 mm; Karl Storz GmbH, Tuttlingen, Germany) with a 275 
μm laser fiber). Procedure ended when no fragment remained in the 
whole ureter or residual fragments were estimated that all would pass 
spontaneous (fragment size less than 2 mm using de 1 mm wide guire 
as the referent). An open double-J stent and urethral Foley catheter 
were left in situ. The urethral catheter was removed after 24 hours 
and discharged. The double J catheter was removed after 10-15 days. 
To assess therapy outcome, X-ray was usually performed 15 days 
after URSL. The therapy was regarded as successful and the patient 
as stone free, when no more treatable stones were seen (no stone or 
stone<3 mm). Re-treatment (rescue ureteroscopy) was performed in 
cases of residual stones of >3 mm without spontaneous passage until a 
maximum of four weeks after removing double-J stent. Complete stone 
clearance was assessed at three months follow up. 
Outcomes measure
The treatment results of the two different strategies were compared 
with the stone free rate (SFR), defined as the absence of lithiasis 
fragments or the presence of clinically insignificant residual fragments 
(CIRFs) - less than 3 mm - at the 3 month follow up. This was 
determined by kidney-ureter-bladder X-ray or non-contrast enhanced 
computerized tomography. The rate of complications was performed 
by monitoring immediate and post-operative complications for each 
technique. The Clavien-Dindo classification was used for categorization 
and analysis. The complications included to develop the analysis were 
those that required hospitalization or unplanned ancillary procedures.
Costs measure
In this study, we calculated the overall hospitalization cost, and 
the overall postoperative laboratory and radiology test cost for both 
techniques. The hospitalization cost included the hospital stay, 
anesthesia, procedure, pharmacy, supplies, disposable materials, 
stents and catheters. In addition, the postoperative visit cost was 
also recorded. The data of the global expenditure were extracted 
from the economic information service hospital and are shown in 
Tables 1 and 2. 
Modeling
An economic evaluation through a cost effectiveness analysis (CEA) 
was performed comparing costs and outcome [3,4]. This is a systematic 
method of comparing two or more alternative programs by measuring 
the costs and consequences (health outcomes) of each [5]. The cost was 
 Unit Cost
Average 
Number Per 
Patient
Total 
Cost Per 
Patient
Total 
Cost (%)
Average Cost 
Per Eswl 
Session
ESWL 335.78 1.93 648.06 62.6 335.78
Consultations 39.75 3.04 120.84 11.7 62.61
Urgencies 170.34 0.15 25.551 2.5 13.24
Hospital stays 
(Adverse 
Events)
417.57 0.06 25.05 2.4 12.98
JJ Withdrawal 101 0.09 9.57 0.9 4.96
RX 28.31 2.67 75.59 7.3 39.16
Ecography 37.41 1.32 49.38 4.8 25.59
Computer 
Tomography 
without contrast
18.68 0.09 1.68 0.2 0.87
IV Urography 440 0.18 79.20 7.7 41.04
Total   1034.92 100.0 536.23
Table 1: ESWL cost analysis.
 Unit Cost
Average 
Number 
Per 
Patien
Total 
Cost Per 
Patient
 Total 
Cost 
(%)
Average 
Cost Per Ursl 
Session
Ursl 1900.13 1.03 1,957.13 85.5 1900.13
Consultations 39.75 1.77 70.36 3.1 68.31
Urgencies 170.34 0.09 15.33 0.7 14.88
Hospital Stays 
(Adverse Events) 417.57 0.19 79.34 3.5 77.03
Jj Withdrawal 101 0.74 74.74 3.3 72.56
Xray 28.31 1.67 47.28 2.1 45.90
Ecography 37.41 0.56 20.95 0.9 20.34
Computer 
Tomography 
Without Contrast
18.68 0.27 5.04 0.2 4.90
Iv Urography 440 0.04 17.60 0.8 17.09
Total   2,287.77 100.0 2,221.14
Table 2: URSL cost analysis.
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URS in the treatment of ureteral stones. This effectiveness was superior 
when we evaluated according to the size at all locations except in 
ureteral lumbar lithiasis (equal to or larger than one centimeter) and 
iliac ureteral stones (Table 4). 
A decision tree analysis was built for every location and size stone 
and it is shown in Figures 1-5. The ESWL as first treatment line (and 
URSL as second line treatment if ESWL failed) were dominant in all 
cases despite location and size stone versus URSL as first option of 
treatment. The Monte Carlo probabilistic sensitivity analysis showed 
dominance of ESWL as a first line treatment in 100% of cases for the 
lumbar ureter stones lesser than 1 cm and 99.9% in stones larger than 
1 cm. In case of pelvic ureteral lithiasis less than 1 cm, ESWL as initial 
treatment was dominant in 97,1% and non-cost-effective in 2.9%. If 
the lithiasis was equal to or larger than 1 cm the dominance was 94.1% 
and non-cost-effectiveness in 5.6% of cases. In iliac position, ESWL as 
first line treatment showed a dominance of 84.6% was cost-effective in 
3.7% and non-cost-effective in 11.9% of cases (Table 5 and Figures 6-9). 
In any case, the initial strategy with ESWL in the treatment of 
ureteral stones was always equally or more effective than URSL with 
lower economics costs. 
Regarding the safety profile, the ESWL showed higher adverse 
events (18.95%) than the URSL (2.35%). The adverse events in the 
ESWL were mainly mild and classified as a Clavien I (83.3%). The 
comparison of complication rate and its costs between both groups are 
shown in Table 6. 
Discussion
There are several minimally invasive treatment options for the 
compiled from economic information of hospital and electronic health 
records (EHR) and calculated from the initial procedure, subsequent 
procedures, radiographs, and visits. The study was conducted following 
the economic costs established by the Regional Health Department 
(Conselleria de Sanitat), who is managing public health in our region.
The total cost of a lithotripsy session was 536.26 €, while for an 
ureteroscopy amounts to 2221.14 €, representing almost the cost of 6 
sessions of lithotripsy. A decision tree [6,7] was modeled for the two 
alternatives, ESWL and first line URSL. From our database we obtained 
the probabilities of treatment success for each technique. We calculated 
probabilities of success- in the case of ESWL for 1 to 4 sessions, for 
alternative two URSL after ESWL failure in any of the 4 sessions. In 
the URSL group a limit of two procedures. For both alternatives 
the probability and costs of major and minor complications was 
also estimated. The payoff for each group is measured as the of free 
stone patients rate. Using this model, we estimated the incremental 
cost effectiveness ratio (ICER) [5]. This ratio compares the costs 
(incremental costs) and outcomes (incremental effect) from ESWL vs. 
URSL 
ESWL URSLC C C∆ = −
ESWL URSLE E E∆ = −
ICER C E= ∆ ÷ ∆
A decision tree analysis was designed to discriminate by lithiasis 
location (ureter lumbar, iliac and pelvic) and size (less than 1 cm or 
equal to or larger than 1 cm). For the iliac ureteral stones, we analyzed 
without stratification by size due to the small size of the sample. Finally, 
we conducted a Monte Carlo simulation for a probabilistic sensitivity 
analysis [6,8,9]. The procedure to generate sample distribution for ICER 
was as follows: One sample of costs (C) and health effects (E) from the 
distribution of costs and effects from ESWL: CESWL and ESWL, and 
one sample of cost and effects from the distribution of costs and effects 
of URSL: CURS and EURSL were taken. CURSL - CESWL divided by 
EURSL-ESWL, and then gave the sample estimate of the incremental 
CER. This process was repeated a large number of times (1,000 in our 
case) to give a vector of sample estimate that is the empirical sampling 
distribution of the incremental CER statistic (β distribution parameter 
was assumed). When the patient has not stone free after undergoing 
one of the two treatments, the salvage technique was laparoscopy. The 
cost of this surgery is 5,000 euros, so this was the threshold of cost 
effectiveness [10] chosen for the model (5,000 € per patient stone free). 
Statistical analysis
Assuming a SFR with ESWL Group of 81% and an expected rate 
of nearly 94% with URSL Group, the sample size for each group was 
calculated as 79 (power>80%) with a type I error rate<0.05.
Chi-quare statistics were calculated for categorical variables 
with the Fischer exact test used to calculate P value, with continuous 
variables being tested with the Student T. P values were two-sided, and 
<0.05 was statistically significant. 
Results
The patient characteristics and comparison between groups, are 
shown in Table 3. Both groups were comparable except for the variables 
sex, mean age and stone location, which showed statistically significant 
differences. The average age was higher in the Group B (URSL) and 
males were treated mostly with ESWL.
The global analysis of the SFR between therapeutic modality initially 
elected, regardless rescue techniques, showed greater effectiveness of 
 Variable
ESWL URSL p value
Age  Mean (SD) Mean (SD)
0.002*
  51.78 (11.79) 57.52 (14.04)
n/total (%) n/total (%)  
Sex Male 68/112 (60.71) 44/112 (39.28)
0.010^
 Female 27/68 (39.70) 41/68 (60.29)
Stone size <1 cm 60/109 (55.05) 49/109 (44.95)
0.450^
 ≥1 cm 35/71 (49.30) 36/71 (50.70)
Position Lumbar ureter 68/92 (73.91) 24/92 (26.09)
0.000^ Iliac ureter 4/25 (16.00) 21/25 (84.00)
 Pelvic ureter 23/63 (36.51) 40/63 (63.49)
*Student´s test
^Chi square test
Table 3: Patient and Stone Characteritics. comparison between Both Groups.
Initial Treatment With Rescue Treatment
Location Size ESWL       n (%)
URSL
n (%) p value
4SWL + 
2URSL
n(%)
2 URSL
n(%)
Lumbar <1 cm 38 (86.36) 10 (100) 0,215* 44 (100)      ------
 ≥1 cm 19 (79.17) 10 (71.42) 0,588* 23 (98,51) 13 (92,86)
Iliac All sizes 4 (100) 20 (95.83) 0,656* ----- 20 (95,83)
Pelvic <1 cm 10 (66.67) 28 (100) 0,001* 15 (100) ------
 ≥1 cm 6 (75) 12 (100) 0,068* 8 (100) ------
Global 77(81) 80 (94)  0,001*
<1 cm 49(83) 49(98)
≥1 cm 28 (78) 32(91)
Table 4: Stone free rate between groups, Comparison between initial and rescue 
treatment.
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ureteral stones. The properly option depend on the stone characteristics 
(size, hardness and location), the available technology, surgeon’s 
experience, success rate of each technique, predictors of failure and 
patient preference. Recently, there have been significant advances in 
the technology of both techniques. The lithotripters generate waves 
with higher positive peak pressure, the focal areas are smaller and 
better tolerated by patients. It is a safe and effective alternative, with 
SFR between 50-86% for ureteral lithiasis. However, the re-treatment 
rate is high (11-33%) and have not improved success rates achieved by 
the gold standard (HM3 lithotripter). The URSL and laser technology 
have also improved in recent years. This advance allowed an increase 
success rate (79-99%), with a slightly higher complications rate (7-
13%) if we compare with lithotripsy. The principal advantages of the 
ESWL are that it can be performed under intravenous sedation, it is a 
SUCCES SUCCES SUCCES SUCCES SUCCES
50.86% 19.33% 0.00% 18.04% 10.40%
2nd ESWL 3rd ESWL 4th ESWL
1st ESWL 49.14% 29.81% 28.44%
100.00% 263.49 € FAIL 159.83 € FAIL 152.50 € FAIL
536.23 € FAIL 29.81% 29.81% 10.40% 10.40%
49.14% 231.01 € FAIL
0.00%
SUCCES SUCCES SUCCES
0.00% 0.00% 1.37%
0.00% 0.00% 1.37%
Uretheral 0.00 € FAIL 0.00 € FAIL 30.38 € FAIL
Lithiasis 0.00% 0.00% 0.00%
SUCCES
100.00%
 1st URS SUCCES
100.00% 0.00%
2,221.14 € FAIL 2nd URS
0.00% 0.00%
0.00 € FAIL
0.00%
URS        
(1st & 2nd)
URS       
(1st & 2nd)
URS        
(1st & 2nd)
URS       
(1st & 2nd)
ESWL Eﬃcacy
100.00%
ESWL Cost
URS Eﬃcacy URS Cost
1,373.44 €
ICER ESWL vs URS
- DOMINANT
100.00%
Incr. Eﬃcacy
0.00%
Incr. Costs
2,221.14 €
-847.70 €
Figure 1: Decision tree for lumbar ureteral stone less than 1 cm.
SUCCES SUCCES SUCCES SUCCES SUCCES
37.50% 16.67% 16.67% 8.33% 11.61%
2nd ESWL 3rd ESWL 4th ESWL
1st ESWL 62.50% 41.67% 20.83%
100.00% 335.14 € FAIL 223.43 € FAIL 111.71 € FAIL
536.23 € FAIL 45.83% 25.00% 12.50% 12.50%
62.50% 356.97 € FAIL
0.89%
SUCCES SUCCES SUCCES
0.00% 3.87% 3.87%
0.00% 4.17% 4.17%
Ureteral 0.00 € FAIL 118.99 € FAIL 118.99 € FAIL
Lithiasis 0.00% 0.30% 0.30%
SUCCES
71.43%
 1st URS SUCCES
100.00% 21.43%
2,221.14 € FAIL 2nd URS
28.57% 28.57%
634.61 € FAIL
7.14%
ICER ESWL vs URS
- DOMINANT
92.86%
Incr. Eﬃcacy
5.65%
Incr. Costs
2,855.75 €
-1,054.29 €
98.51%
ESWL Cost
URS Eﬃcacy URS Cost
1,801.46 €
URS        
(1st & 2nd)
URS       
(1st & 2nd)
URS        
(1st & 2nd)
URS       
(1st & 2nd)
ESWL Eﬃcacy
Figure 2: Decision tree for lumbar ureteral stone equal to or larger than 1 cm.
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less invasive technique, with good tolerability and minimal side effects. 
Nevertheless, URSL requires general or spinal anesthesia, but it has 
shown a high success rate and a low probability of retreatments. To date, 
few studies have compared the optimal therapy in the management 
of ureteral stones. In our knowledge, this is the first study that uses a 
decision tree and sensitivity analysis to evaluate the efficiency of two 
different minimally invasive treatment strategies in ureteral lithiasis, 
including not only the initial treatment but also retreatments, auxiliary 
maneuvers and complete follow up until resolution of the case. Thus, 
we evaluated the effectiveness of two strategies in the treatment of 
ureteral lithiasis and not just the initial treatment of choice. Despite the 
great heterogeneity and limited quality of available cost-effectiveness 
evaluations most studies demonstrated that URSL was more favorable 
than ESWL for ureteral stones in terms of stone-free rate and cost [11]. 
However, if we analyze overall available studies we can see significance 
differences between effectiveness and cost, depending on countries 
SUCCES SUCCES SUCCES SUCCES SUCCES
50.00% 0.00% 50.00% 0.00% 0.00%
2nd ESWL 3rd ESWL 4th ESWL
1st ESWL 50.00% 50.00% 0.00%
100.00% 268.11 € FAIL 268.11 € FAIL 0.00 € FAIL
536.23 € FAIL 50.00% 0.00% 0.00% 0.00%
50.00% 0.00 € FAIL
0.00%
SUCCES SUCCES SUCCES
0.00% 0.00% 0.00%
0.00% 0.00% 0.00%
Uretheral 0.00 € FAIL 0.00 € FAIL 0.00 € FAIL
Lithiasis 0.00% 0.00% 0.00%
SUCCES
95.24%
 1st URS SUCCES
100.00% 0.00%
2,221.14 € FAIL 2nd URS
4.76% 4.76%
105.77 € FAIL
4.76%
URS        
(1st & 2nd)
URS       
(1st & 2nd)
URS        
(1st & 2nd)
URS       
(1st & 2nd)
ESWL Eﬃcacy
100.00%
ESWL Cost
URS Eﬃcacy URS Cost
1,072.46 €
ICER ESWL vs URS
- DOMINANT
95.24%
Incr. Eﬃcacy
4.76%
Incr. Costs
2,326.91 €
-1,254.45 €
Figure 3: Decision tree for iliac ureteral stone (all sizes).
SUCCES SUCCES SUCCES SUCCES SUCCES
53.33% 20.00% 0.00% 0.00% 13.33%
2nd ESWL 3rd ESWL 4th ESWL
1st ESWL 40.00% 13.33% 13.33%
100.00% 214.49 € FAIL 71.50 € FAIL 71.50 € FAIL
536.23 € FAIL 20.00% 13.33% 13.33% 13.33%
46.67% 296.15 € FAIL
0.00%
SUCCES SUCCES SUCCES
6.67% 6.67% 0.00%
6.67% 6.67% 0.00%
Uretheral 148.08 € FAIL 148.08 € FAIL 0.00 € FAIL
Lithiasis 0.00% 0.00% 0.00%
SUCCES
100.00%
 1st URS SUCCES
100.00% 0.00%
2,221.14 € FAIL 2nd URS
0.00% 0.00%
0.00 € FAIL
0.00%
URS        
(1st & 2nd)
URS       
(1st & 2nd)
URS        
(1st & 2nd)
URS       
(1st & 2nd)
ESWL Eﬃcacy
100.00%
ESWL Cost
URS Eﬃcacy URS Cost
1,486.02 €
ICER ESWL vs URS
- DOMINANT
100.00%
Incr. Eﬃcacy
0.00%
Incr. Costs
2,221.14 €
-735.12 €
Figure 4: Decision tree for pelvic ureteral stone less than 1 cm.
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and technologies. Furthermore, in most studies the criteria to evaluate 
the effectiveness of ESWL is not clear, as the author has not shown if 
the stone free rate is initial or after having completed the follow-up 
period. The studies that show initial and global SFR obtain 60% and 
90% respectively [12,13]. However URSL in all studies, improve these 
figures achieving an initial SFR around 90%.
In evaluations performing in USA the cost for ESWL was highest 
and URSL was most favorable in cost effectiveness analysis [14-
16]. Parker y colleagues treated 220 patients with proximal ureteral 
calculi using ESWL or ureteroscopy and found that URSL was more 
efficient with similar complications rate. The total charge for URS 
were $9378 which is lower than those of ESWL with total charges of 
$15583. However, the effectiveness of lithotripsy was lower compared 
to other studies and methodology used did not specified the direct 
cost from the treatment and follow up, but with the total invoice for 
the patient’s treatment. Matlaga [17] in a systematic review, described 
the URSL was associated with a better SFR with and lower economic 
cost than URSL, thus being dominant over the ESWL. However, the 
authors acknowledge that it is very difficult to assess the magnitude of 
benefit of URSL respect to cost, given the wide variety of existing health 
systems. Other authors such as Chandhoke [18] obtained similar 
results to those described. Other studies in different health systems also 
showed similar results. In Egypt, Salem [19], in a prospective study of 
proximal ureter lithiasis, found similar results. In lithiasis larger than 
1 cm (Figure 10), the SFR of URSL was significantly better than the 
ESWL (88% vs 60%), although stones smaller than 1 cm found no 
significant differences (100% vs 80%). The costs were initially higher 
in the URSL compare with ESWL ($ 1026 vs $ 1170), but when the 
overall costs were evaluated including additional procedures, visits and 
explorations, the ESWL was more expensive than the URSL ($ 6500 vs 
$ 5700). An analysis Performed in Malaysia showed also similar results 
[11], although either lithotripsy or ureteroscopy had low efficiency. 
The efficiency analysis was made with quality of life questionnaire (SF 
-36), and the study identified lower costs for the ureteroscopy group. 
However, the group that received lithotripsy had a larger median 
size of the stones than the ureteroscopy group, which may limit the 
effectiveness results, as well as it was a retrospective study design with 
a small sample. On the other hand, the higher cost of lithotripsy was 
linked it to the cost of purchasing and maintenance of the lithotripter. 
Cui et al. [20] found a high effectiveness with both treatments, but the 
cost was significantly lower for the ESWL without differences in the 
rate of severe complications. The recovery time was significantly lower 
in the ESWL group compared with the URSL group, and the lower 
urinary tract symptoms rates were higher for the group of the URSL. 
Zhang et al. [21] found no difference between the two techniques in 
the ureter lumbar location. In the distal location, the URSL was more 
effective, but the cost was favorable to lithotripsy in all locations. 
However, in Zhang et al. [21] study all necessary preoperative tests were 
performed on an inpatient basis in both forms of treatment therefore 
SUCCES SUCCES SUCCES SUCCES SUCCES
75.00% 0.00% 0.00% 0.00% 25.00%
2nd ESWL 3rd ESWL 4th ESWL
1st ESWL 25.00% 25.00% 25.00%
100.00% 134.06 € FAIL 134.06 € FAIL 134.06 € FAIL
536.23 € FAIL 25.00% 25.00% 25.00% 25.00%
25.00% 555.28 € FAIL
0.00%
SUCCES SUCCES SUCCES
0.00% 0.00% 0.00%
0.00% 0.00% 0.00%
Uretheral 0.00 € FAIL 0.00 € FAIL 0.00 € FAIL
Lithiasis 0.00% 0.00% 0.00%
SUCCES
100.00%
 1st URS SUCCES
100.00% 0.00%
2,221.14 € FAIL 2nd URS
0.00% 0.00%
0.00 € FAIL
0.00%
URS        
(1st & 2nd)
URS       
(1st & 2nd)
URS        
(1st & 2nd)
URS       
(1st & 2nd)
ESWL Eﬃcacy
100.00%
ESWL Cost
URS Eﬃcacy URS Cost
1,493.68 €
ICER ESWL vs URS
- DOMINANT
100.00%
Incr. Eﬃcacy
0.00%
Incr. Costs
2,221.14 €
-727.45 €
Figure 5: Decision tree for pelvic ureteral stones equal to or larger than 1 cm.
Group A: SWL  
(+ URS as rescue treatment)
Group B: URS  
(+ second URS as rescue treatment)  Group A vs Group B
SFR COST SFR COST RESULT
Lumbar<1cm 100.00% 1.373.44 € 100.00% 2.221.14 € Dominant
Lumbar  ≥ 1cm 98.51% 1.801.46 € 92.86% 2.855.75 € Dominant
Iliac. All sizes 100.00% 1.074.72 € 95.24% 2.326.91 € Dominant
Pelvic.<1 cm 100.00% 1.486.02 € 100.00% 2.221.14 € Dominant
Pelvic.>1 cm 100.00% 1.493.68 € 100.00% 2.221.14 € Dominant
Table 5: Cost-effectiveness results.
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it produced an increase of the cost of stay. Moreover, the cost of the 
laser in the group of the URSL was billed by pulses used, which makes 
it difficult to compare with other studies of similar characteristics. 
So, ESWL costs were very low compared to European or American 
studies because lithotripters are self-made and their acquisition and 
maintenance costs are reduced significantly. Unlike other studies, we 
used our real terms of effectiveness, allowing us in daily practice to 
make informed decisions based on terms of cost-effectiveness of our 
own environment. Although we are agree with Cone et al. [22] that 
clinical decisions should not be based only in terms of costs. At least 
we should analyze the total cost of each technique before decide one 
treatment option. 
Our report has several points of strength. It is a prospective study 
with a large number of patients, with an exact definition of the size, 
location, SFR, time in which it is determined the SFR, complications 
and retreatments as well as rescue treatments performed. The 
methodology uses as a therapeutic decision tree or a sensitivity analysis 
provide strength in our results. 
However, the main limitations of our study were the small number 
of patients with iliac stones, which did not allow us to stratify according 
to size. The treatment election was performed by patient decision after 
receiving complete information about the different procedures, making 
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Figure 6: Cost-effectiveness plane (Montecarlo simulation) for lumbar ureteral 
lithiasis less than 1 cm.
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Figure 7: Cost-effectiveness plane (Montecarlo simulation) for lumbar ureteral 
stone equal to or larger than 1 cm.
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Figure 8: Cost-effectiveness plane (Montecarlo simulation) for iliac ureteral 
stone.
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Figure 9: Cost-effectiveness plane (Montecarlo simulation) for ureteral pelvic 
lithiasis less than 1 cm.
All Sizes and positions
Complications Clavien Costs (€) ESWL n(%) URSL n(%)
Without complications   77 (81.05) 83 (97.65)
Renal colic
Urinary infection
1
2
   162.11
   162.11
13 (13.68) 
    4 (4.21)
  0(0)
  1 (1.18)
Hematoma 2 2.228.81     0 (0.00)   1 (1.18)
Sepsis 4 3.902.92     1 (1.05)   0 (0)
 Lumbar Lithiasis
Stones < 1 cm
Complications Clavien Costs € ESWL URSL
Without Complications   35 (79.55) 10 (100)
Renal Colic
Urinary Infection
1
2
   162.11
   162.11
  6 (13.64)
  2   (4.55)
 0(0) 
 0 (0)
Sepsis 4 3.902.92   1  ( 2.27)  0 (0)
Stones ≥ 1 cm
Complications Clavien Costs € ESWL URSL
Without Complications  21 (87.50) 13 (92.86)
Renal Colic
Hematoma
1
2
   162.11
2.228.81
  3 (12.5)
  0   (0)
  
  1   (7.14)
Iliac Lithiasis (all sizes)
Complications Clavien Costs € ESWL URSL
Without Complications   2 (75.00) 21(100)
Renal Colic
Urinary Infection
1
2
162.11
162.11
1 (25.00)
1 (25.00)
  0(0)
0 (0)
Pelvic Lithiasis
 Stones < 1 cm
Complications Clavien Costs € ESWL URSL
Without Complications   14 (93,33) 28 (100)
Renal Colic 1 162.11   1 (6,67)   0 (0)
Stones ≥ 1 cm
Without 
Complications  5 (62,5) 11 (91,67)
Renal Colic
Urinary Infection
1
2
162.11
162.11
2 (25,00)
1 (12,5)
 0 (0) 
1 (8,33)
Table 6: Analysis of adverse events.
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it impossible randomization in both study groups. Likewise, indirect 
costs (patient and family) associated with the period of convalescence 
of each therapeutic modality were not considered. In addition, we did 
not take into account the quality of life and patient satisfaction. This 
analysis should provide a fuller comparison of both techniques.
Conclusions
The results of our study show that the ESWL as an initial treatment 
strategy is more efficient in terms of cost-effectiveness than URSL as 
initial treatment in the treatment of ureteral stones, regardless of the size 
of the calculi, in our country. In our opinion, urologists should evaluate 
the economic impact of treatment stone with the goal of maximizing 
clinical and economic outcomes besides patient satisfaction. 
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Figure 10: Cost-effectiveness plane (Montecarlo simulation) for ureteral pelvic 
lithiasis equal to or larger than 1 cm.
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